Comparing the effectiveness of the drugs between Carbetocin and Oxytocin in the prevention of heavy blood loss during normal vaginal delivery

A Quasi experimental study to compare the efficacy of Carbetocin and Oxytocin in preventing post partum hemorrhage during vaginal delivery in a tertiary care center in Chengalpattu district - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062430

Enrollment

Registered

2024-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Oxytocin: Oxytocin is the drug of choice to prevent and treat Post partum hemorrhage. The half-life of oxytocin ranges from 1-6 minutes. Control Intervention1: Carbetocin: Carbetocin, a

Eligibility

Inclusion criteria

Inclusion criteria: SINGLETON PREGNANCY TERM(37 TO 40 WEEKS OF GESTATION) VAGINAL DELIVERY

Exclusion criteria

Exclusion criteria: AGE ABOVE 35 YEARS PREVIOUS LOWER SEGMENT CAESAREAN SECTION INSTRUMENTAL VAGINAL DELIVERY INCLUDING FORCEPS OR VACUUM ASSISTED COMPLETE PERINEAL TEAR DURING NORMAL VAGINAL DELIVERY HIGH RISK PREGNANCIES INCLUDING ANTEPARTUM HEMORRHAGE PLACENTA PREVIA ABRUPTIO PLACENTA PIH PRE ECAMPSIA ECLAMPSIA GDM MULTIPLE PREGNANCIES POLYHYDRAMNIOS MACROSOMIA

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of carbetocin with oxytocin in control of post partum hemorrhageTimepoint: 2 hours	—

Secondary

Measure	Time frame
To study the safety & the additional need of uterotonic agent following carbetocin & oxytocin administration in prevention of post partum hemorrhage in 24 hoursTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDrMonisha S

Shri Sathya Sai Medical College and Research institute

ushag7@hotmail.com9940306107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026